Adial Pharma: Up on distribution deal for COVID-19 antibody tests

Todos Medical

22/10/2020 17:34

** Addiction treatment developer's shares  ADIL.O  up 4.6%
at $1.79
    ** Co enters distribution agreement with Todos Medical Ltd
 TOMDF.PK  for its COVID-19 point-of-care antibody tests
 urn:newsml:reuters.com:*:nGNX2rJtx4
    ** As per terms of deal, Adial has granted Todos Medical
non-exclusive sub-distribution rights to its Assure/FaStep and
EcoStep point-of-care antibody tests 
    ** Assure/FaStep test, which received U.S. FDA emergency use
authorization in Sept, uses fingerstick blood samples as
compared with current approved tests that only utilize serum,
plasma, or a venous blood draw
    ** ADIL stock down ~26% YTD

 (Reporting By Mrinalika Roy in Bengaluru)
 ((mrinalika.roy@thomsonreuters.com; within U.S. +1 646 223
8780, outside U.S. +91 806749 8325;))